Home » Topics » BioWorld Science

BioWorld Science
RSS

eFFECTOR Therapeutics describes MNK1 and MNK2 inhibitors

May 10, 2019

Epizyme discloses EHMT1 and/or EHMT2 inhibitors

May 10, 2019

Incyte patents PI3Kgamma inhibitors

May 10, 2019

Bristol-Myers Squibb presents new hSTING agonists

May 10, 2019

CAR T-cell therapy targeting AMHR2, a potential treatment for ovarian cancer

May 10, 2019

First clinical results on K-0706 presented as potential treatment for Parkinson's disease

May 10, 2019

Nintedanib ophthalmic nanosuspension tested in animal model as pterygium treatment

May 10, 2019

resTORbio initiates phase III program of RTB-101 in clinically symptomatic respiratory illness

May 10, 2019

CheckMate498 phase III study of Opdivo does not meet primary endpoint

May 10, 2019

Dosing begins in phase IIa PANASH study of liver stem cell therapy in late-stage NASH

May 10, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...